Aerpio Pharmaceuticals
0 sources
Financials
0001583771-24-000003Aerpio Pharmaceuticals
Summary
Aerpio Pharmaceuticals is a business[1].
Key Facts
- Aerpio Pharmaceuticals is in the country of United States[2].
- Aerpio Pharmaceuticals is in the country of US[3].
- Aerpio Pharmaceuticals's instance of is recorded as business[4].
- Aerpio Pharmaceuticals's headquarters location is recorded as Cincinnati[5].
- January 1, 2007 marks the founding of Aerpio Pharmaceuticals[6].
- 2007-11-16 marks the founding of Aerpio Pharmaceuticals[7].
- Aerpio Pharmaceuticals's official website is recorded as https://aerpio.com/[8].
- Aerpio Pharmaceuticals's legal form is recorded as XTIQ[9].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 549300G3U7TKW1M58L09[10]
-
Registered legal name: Aadi Bioscience, INC.[11]
-
Legal jurisdiction: US-DE[12]
-
GLEIF entity category: GENERAL[13]
-
Legal form (ISO 20275 ELF): XTIQ[14]
-
Entity status: ACTIVE[15]
-
LEI registration status: LAPSED[16]
-
Entity created: 2007-11-16[17]
-
LEI first registered: 2017-04-20[18]
-
LEI last updated: 2024-09-10[19]
-
LEI next renewal: 2018-04-18[20]
-
Managing LOU: 5493001KJTIIGC8Y1R12[21]
-
Registration authority: RA000602[22]
-
Authority entity ID: 4459056[23]
-
Other names: Zeta Acquisition Corp Ii, Aerpio Pharmaceuticals, Inc.[24]
-
Conformity flag: NON_CONFORMING[25]
Body
Founding
Recorded inception include January 1, 2007[6] and 2007-11-16[7].
Operations
Aerpio Pharmaceuticals's headquarters location is recorded as Cincinnati[5].